Clinical Trials Logo

Clinical Trial Summary

Vitiligo is a relatively common acquired disorder of pigmentation characterized by the development of well-defined white macules on the skin. Biopsies of lesional skin reveal a loss of epidermal melanocytes. Lesions may occur in a localized or generalized distribution and may coalesce into large, depigmented areas. Given the contrast between the white areas and normal skin, the disease is most disfiguring in darker skin types and has a profound impact on the quality of life of both children and adults . Patients with vitiligo often experience stigmatization, social isolation, and low self-esteem. The therapys include topical steroids, topical immunosuppresant, systemic steroids, phototherapy, and surgery.

The aim of this study is to investigate the effect of phototherpy and accupuncture combined therapy for vitiligo patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Brief Description of Focus of Study Instead
  • Vitiligo

NCT number NCT03718962
Study type Interventional
Source Shin Kong Wu Ho-Su Memorial Hospital
Contact
Status Completed
Phase N/A
Start date October 30, 2018
Completion date January 30, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05000814 - Study of Cost-effectiveness of the Airway Management in Thoracic Surgery